Ventrus Biosciences Inc. (VTUS)

[lecorb]

Analyst Ratings for Ventrus Biosciences (VTUS)

Overall Rating: BUY Rating Trend: Up Avg. $ Target: $18.83 (+1062.6%)

2/12/2014 Cantor Fitzgerald Downgrade Hold
(Buy) 2.50
(6.00) 4.38 1.62 -63.01% Details
2/12/2014 William Blair Downgrade Market Perform
(Outperform) N/A
(10.00) 4.38 1.62 -63.01% Details
6/14/2012 Brean Capital New Coverage Buy
(N/A) 30.00
(N/A) 10.04 1.62 -83.86% Details
7/25/2011 Lazard Capital New Coverage Buy
(N/A) 24.00
(N/A) 11.89 1.62 -86.38% Details
7/25/2011 Leerink Swann New Coverage Outperform
(N/A) N/A
(N/A) 11.89 1.62 -86.38% Details
2/2/2011 Rodman & Renshaw New Coverage Market Outperform
(N/A) N/A
(N/A) 6.14 1.62 -73.62% Details
1/27/2011 National Securities New Coverage Buy
(N/A) N/A
(N/A) 6.41 1.62 -74.73% Details

http://www.streetinsider.com/rating_history.php?q=VTUS